Who invested in RxAnte?
RxAnte's investors include Trinity Capital, Aberdare Ventures and West Health Investment Fund.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$4.6Mraised across 3 rounds since 2012, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by prnewswire.comSEC filing: $4.6M sold, first sale Aug 2012
No investor was named in the report.
Reported by sec.govSEC filing: $4.6M sold, first sale Aug 2012
From the SEC filings it signed: 6 on the team.
On the board, as filediBrenton BurnsChronis ManolisJonathan PhillipsMohit KaushalNicholas Shapiro
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
RxAnte's investors include Trinity Capital, Aberdare Ventures and West Health Investment Fund.
RxAnte has raised $4.6M across 3 rounds since 2012. 2 rounds did not disclose an amount, so the total is a floor.
RxAnte's most recent round was a Venture in Jan 2026.
RxAnte's largest round on record is $4.6M (Growth), in Sept 2012.
RxAnte's first round on record, in Sept 2012, was backed by Aberdare Ventures and West Health Investment Fund.
RxAnte's latest named round is a Venture, in Jan 2026.
RxAnte is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.